UnknownNot Applicable

Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging

Egypt24 participantsStarted 2017-12-01

Plain-language summary

Differentiation between benign and malignant mediastinal tumors as well as characterization and grading of malignancy which is essential for treatment planning as well as for prognosis

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any age groups * diagnosis of mediastinal mass (by Multislice Computed Tomography). Exclusion Criteria: * chemotherapy radiotherapy. * thoracic surgery. * cystic mass . * mass with large amount of necrosis or calcification. * contraindication of MRI (e.g. pacemakers , claustrophobia).

What they're measuring

sensitivity and specificity of magnetic resonance imaging diffusion in mediastinal masses

Timeframe: up to one month

Trial details

NCT IDNCT03214341

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-01

Contact for this trial

Noha Mohammed Ali Attia, lecturer

00201001238435 nohamohammedali@yahoo.com

View on ClinicalTrials.gov More Mediastinal Tumor trials